Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. - Wikidata - wikimedia - TriplyDB

Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate.

Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate.

http://www.wikidata.org/entity/Q34318938

about

Rodent Hypoxia-Ischemia Models for Cerebral Palsy Research: A Systematic Review Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy Mechanisms of perinatal arterial ischemic stroke Topiramate treatment is neuroprotective and reduces oligodendrocyte loss after cervical spinal cord injury Glutamate receptor ion channels: structure, regulation, and function AMPA-Kainate Receptor Inhibition Promotes Neurologic Recovery in Premature Rabbits with Intraventricular Hemorrhage Maternal omega-3 fatty acid supplementation protects against lipopolysaccharide-induced white matter injury in the neonatal rat brain Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia.Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI)Pathophysiology of glia in perinatal white matter injury.CSAX: Characterizing Systematic Anomalies in eXpression Data.Neuroimaging in cerebral palsy: Patterns of brain dysgenesis and injury.Progress in periventricular leukomalacia.NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia.Comparative analysis of the beneficial effects of treadmill training and electroacupuncture in a rat model of neonatal hypoxia-ischemia Synergistic neuroprotective therapies with hypothermia.Timing of appearance of late oligodendrocyte progenitors coincides with enhanced susceptibility of preterm rabbit cerebral white matter to hypoxia-ischemia.The challenge of understanding cerebral white matter injury in the premature infant.Hypoxic ischemic brain injury: Potential therapeutic interventions for the future.The immune response after hypoxia-ischemia in a mouse model of preterm brain injury.Protective Effects of Berberine on Oxygen-Glucose Deprivation/Reperfusion on Oligodendrocyte Cell Line (OLN-93).Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. II. Human cerebral white matter and cortex.Altered glutamatergic metabolism associated with punctate white matter lesions in preterm infants Talampanel suppresses the acute and chronic effects of seizures in a rodent neonatal seizure model.The developing oligodendrocyte: key cellular target in brain injury in the premature infant Developmental expression of N-methyl-D-aspartate (NMDA) receptor subunits in human white and gray matter: potential mechanism of increased vulnerability in the immature brain Hyperoxia causes maturation-dependent cell death in the developing white matter.Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. I. Rodent cerebral white matter and cortex.Neuroprotective potential of erythropoietin and its derivative carbamylated erythropoietin in periventricular leukomalacia Oxidative stress disrupts oligodendrocyte maturation.Mouse models of periventricular leukomalacia Cell replacement therapy in neurological disease.Axon-glia synapses are highly vulnerable to white matter injury in the developing brain Systemic prenatal insults disrupt telencephalon development: implications for potential interventions.Strain-specific differences in perinatal rodent oligodendrocyte lineage progression and its correlation with human.Glia Disease and Repair-Remyelination Roles of white matter in central nervous system pathophysiologies.Oligodendrocytes Are Targets of HIV-1 Tat: NMDA and AMPA Receptor-Mediated Effects on Survival and Development.Progenitor cell-based treatment of the pediatric myelin disorders Role of glutamate receptors in periventricular leukomalacia.

P2860

Q26747485-7DA43EB9-1B7A-41F6-89AB-247C9B997D1D Q26782756-B16BF6CF-2ECB-44BD-9D90-6EA60CA68A03 Q26998918-C94F5623-B4FF-4341-BC24-06378FA8C23E Q27306821-A01B1610-83F4-44E0-A18F-E845E9AA3676 Q28290774-6EBD111D-334E-4BEA-8FE9-0CB1BE8EA953 Q28389765-04559C74-1529-4592-99BC-71DEB5623351 Q28567546-DB618DEC-6B79-4E49-B5D9-D7433C62557A Q30405077-8FAF7A23-95B2-4FD0-AC8E-68697EECC216 Q30462209-7983E9EB-28A7-4691-AD35-F0A4DF5E0F5D Q30790294-1441861D-7F20-4248-8A97-A4C7CA332A4E Q30887501-56768484-7DC1-491E-9724-4D62BD53A571 Q33231806-F5175B71-D613-4056-93CD-C572C3710676 Q33375579-62220C00-9C1A-45B4-853F-2FFF7AAB5D88 Q33565598-45527B90-CBC6-4B1A-91B9-9C42276F72F6 Q33674966-51386A5F-E12C-48F2-B9FC-EBD250A0E7CC Q33943360-01DE99C2-4EDA-4FBC-B54D-7CA091735D4D Q34042991-FF66987F-F986-4D59-A90D-25539B911D17 Q34098352-E3B33E77-134B-461D-A42E-DE6400A02B5A Q34106605-5A83DF11-5B43-47B7-B090-C14382A3F0E4 Q34233973-DED2D0B8-5969-4800-949A-AAF18FC81842 Q34318643-29C75135-DB55-42DD-A34D-37EF10C8CF4A Q34330653-C944CF56-C29C-49DE-B50D-3851E1786EFE Q34611606-D15E4B85-EDF9-41C1-AD4F-6C6B9950A7A7 Q34946029-D01B8235-5869-4DB5-B6EF-B75C2E970A32 Q34995998-631B2DB6-F9B6-4DB7-89C6-42DF4493C1F4 Q35003575-7E068CF2-666F-4DD7-BFF1-C3A960328DB2 Q35009330-A1F655E1-8780-4613-9F2F-4EBF841D174C Q35037490-9D59DB6F-D816-4B36-919D-9A2FB657E2E3 Q35042888-44512444-04A6-43B8-9015-2F7540173B9C Q35111405-FD579F72-62AF-44A1-AC61-9237091DE707 Q35146798-AF3018C0-C28B-44FA-8E1E-77B626A7BD63 Q35172117-587DB052-9A25-4F49-91A7-EA782BC87473 Q35531951-6CEA5467-2AE0-425D-B6CA-E24DC5027D22 Q35569038-6B5DF16C-4E61-451C-9191-E8060C0FD4B7 Q35576382-1CCB9026-A882-427B-988A-C516139C5279 Q35795587-972BFC8F-72BD-4214-99E6-3150CF4B0DF1 Q35846494-A650D6A9-03CD-4878-9BA9-897835AA03A2 Q35941437-B6C5076D-BDDC-4CCD-83F3-61CE3977087D Q35983132-6F2D1BA7-EC20-434A-B1E5-36CCB4CF64FC Q36370763-E29B4DC4-CF05-470A-8872-683E620C9E3E

P2860

Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate.

http://www.wikidata.org/entity/Q34318938

description

2004 nî lūn-bûn

@nan

2004 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Glutamate receptor-mediated ol ...... rotective role for topiramate.

@ast

Glutamate receptor-mediated ol ...... rotective role for topiramate.

@en

Glutamate receptor-mediated ol ...... rotective role for topiramate.

@nl

type

label

Glutamate receptor-mediated ol ...... rotective role for topiramate.

@ast

Glutamate receptor-mediated ol ...... rotective role for topiramate.

@en

Glutamate receptor-mediated ol ...... rotective role for topiramate.

@nl

prefLabel

Glutamate receptor-mediated ol ...... rotective role for topiramate.

@ast

Glutamate receptor-mediated ol ...... rotective role for topiramate.

@en

Glutamate receptor-mediated ol ...... rotective role for topiramate.

@nl

P1433

Q34318938-7D493A08-3734-4711-91FD-0F65F5A4DB09

P1476

Q34318938-9BD0CCA6-2B71-43D3-9E62-3D6C247A84B7

P2093

Q34318938-2B727DD3-82A6-4C1B-A4B4-ED729471A24D

Q34318938-44CD4654-2543-42B6-950C-7430677C98B4

Q34318938-46F87F87-24E5-43C8-A9FC-82F611A53F07

Q34318938-64AA50DA-FA03-47D3-B232-62BDF9C72BBB

Q34318938-D796A832-610E-45FF-91B9-CEC011A0876F

Q34318938-E4869C02-15DB-4C29-B29D-04022F389EC4

Q34318938-EDB5219F-D0B5-4B2E-8288-5609795CB96E

P304

Q34318938-D06F6A9D-AF0B-478F-809F-12231A46628D

P31

Q34318938-C85B39C5-1EB4-4E4F-9A56-CDBBDE843C06

P356

Q34318938-1152587A-9515-46AF-9DDB-88B03A3E120D

P407

Q34318938-22EE204D-9D20-469D-8AEB-C71A183A242F

P433

Q34318938-DA0A24EF-BC57-410E-93DA-6E483561A65A

P478

Q34318938-08C33713-4EEC-42D5-B2AA-E492BE528D73

P50

Q34318938-34DD7EBF-7C59-4B56-BA6A-10EFBEEA1DE7

P577

Q34318938-8952E4A8-C367-4850-B698-921CAFFE6333

P698

Q34318938-2CEF9C05-22DD-4E8B-9DF3-BEE2BFC839D5

P921

Q34318938-8006C1F1-E738-4067-8048-ED0A4ED405A5

P932

Q34318938-75353AC8-FD76-4400-ABD5-4E330E1A6378

P356

JNEUROSCI.0477-04.2004

P1433

Journal of Neuroscience

P1476

Glutamate receptor-mediated ol ...... protective role for topiramate

@en

P2093

Delia M Talos

http://www.w3.org/2001/XMLSchema#string

Frances E Jensen

http://www.w3.org/2001/XMLSchema#string

Joseph J Volpe

http://www.w3.org/2001/XMLSchema#string

Leon J Massillon

http://www.w3.org/2001/XMLSchema#string

Pamela L Follett

http://www.w3.org/2001/XMLSchema#string

Weimin Dai

http://www.w3.org/2001/XMLSchema#string

Wenbin Deng

http://www.w3.org/2001/XMLSchema#string

P304

4412-4420

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1523/JNEUROSCI.0477-04.2004

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Paul A. Rosenberg

P577

2004-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15128855

http://www.w3.org/2001/XMLSchema#string

P921

oligodendrocyte

P932

6729451

http://www.w3.org/2001/XMLSchema#string